ArticleEmerging infectious diseases2023
Rising Incidence of Sporothrix brasiliensis Infections, Curitiba, Brazil, 2011-2022.
Article in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 29 citations in OpenAlex.
- Epidemiology, Clinicopathological Features, Etiological Spectrum and Outcomes of Subcutaneous Mycoses: A 14-Year Retrospective Study.Journal of fungi (Basel, Switzerland) · 2026Article
- Localized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026.Journal of fungi (Basel, Switzerland) · 2026Article
- Fluorescent Staining Using Blankophor for the Diagnosis of Sporotrichosis on Fresh Biopsies.Mycopathologia · 2026Article
- One Health Approach to Sporothrix brasiliensis: Disinfection Strategies for Control and Prevention.Revista da Sociedade Brasileira de Medicina Tropical · 2026Article
- Environmental isolation ofVeterinary record open · 2025Article
- From neglected to notable: A growing public health challenge driven by hospitalization for sporotrichosis in Pernambuco, Northeast Brazil (2016-2024).PLoS neglected tropical diseases · 2025Article
- Sporothrix brasiliensis Atypical Dimorphism in Tissue.Mycopathologia · 2025Article
- Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil.Emerging infectious diseases · 2025Article
- Prospective Uncontrolled Interventional Study of Itraconazole and β-Glucans (Veterinary sciences · 2025Article
- Emergence of Feline Sporotrichosis near Brazil Border, Argentina, 2023-2024.Emerging infectious diseases · 2025Article
- Extracutaneous sporotrichosis.Clinical microbiology reviews · 2025Review
- New Insights on Transmission of Sporothrix brasiliensis.Mycoses · 2025Article
- Emerging human cases of sporotrichosis associated with feline outbreaks ofCurrent research in microbial sciences · 2025Article
- Analyses of the Genetic Diversity and Population Structures ofJournal of fungi (Basel, Switzerland) · 2024Article
- Fungal primary and opportunistic pathogens: an ecological perspective.FEMS microbiology reviews · 2024Review
- Proceedings of the second international meeting on endemic mycoses of the Americas (IMEMA) and first international symposium on implantation mycoses (ISIM).Medical mycology · 2024Article
- Zoonotic Sporotrichosis outbreak: Emerging public health threat in the Amazon State, Brazil.PLoS neglected tropical diseases · 2024Article
- Review
- Bimodal distribution of azole susceptibility inAntimicrobial agents and chemotherapy · 2024Article
- Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study.The Lancet. Microbe · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zoonotic outbreaks of sporotrichosis are increasing in Brazil. We examined and described the emergence of cat-transmitted sporotrichosis (CTS) caused by the fungal pathogen Sporothrix brasiliensis. We calculated incidence and mapped geographic distribution of cases in Curitiba, Brazil, by reviewing medical records from 216 sporotrichosis cases diagnosed during 2011-May 2022. Proven sporotrichosis was established in 84 (39%) patients and probable sporotrichosis in 132 (61%). Incidence increased from 0.3 cases/100,000 outpatient visit-years in 2011 to 21.4 cases/100,000 outpatient visit-years in 2021; of the 216 cases, 58% (n = 126) were diagnosed during 2019-2021. The main clinical form of sporotrichosis was lymphocutaneous (63%), followed by localized cutaneous (24%), ocular (10%), multisite infections (3%), and cutaneous disseminated (<0.5%). Since the first report of CTS in Curitiba in 2011, sporotrichosis has increased substantially, indicating continuous disease transmission. Clinician and public awareness of CTS and efforts to prevent transmission are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.